Orchard Therapeutics plc Quarterly Current Ratio in % from Q3 2019 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Orchard Therapeutics plc quarterly Current Ratio history and growth rate from Q3 2019 to Q3 2023.
  • Orchard Therapeutics plc Current Ratio for the quarter ending September 30, 2023 was 303 %, a 36.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 303 -173 -36.3% Sep 30, 2023
Q2 2023 314 -240 -43.4% Jun 30, 2023
Q1 2023 338 -295 -46.6% Mar 31, 2023
Q4 2022 383 -296 -43.6% Dec 31, 2022
Q3 2022 476 -143 -23.1% Sep 30, 2022
Q2 2022 554 -46.2 -7.7% Jun 30, 2022
Q1 2022 634 +64.2 +11.3% Mar 31, 2022
Q4 2021 680 +115 +20.4% Dec 31, 2021
Q3 2021 620 -0.46 -0.07% Sep 30, 2021
Q2 2021 600 -93.6 -13.5% Jun 30, 2021
Q1 2021 569 -168 -22.8% Mar 31, 2021
Q4 2020 564 -224 -28.4% Dec 31, 2020
Q3 2020 620 -205 -24.9% Sep 30, 2020
Q2 2020 693 Jun 30, 2020
Q1 2020 738 Mar 31, 2020
Q4 2019 788 Dec 31, 2019
Q3 2019 825 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.